• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳腺癌中的组织蛋白酶D

Cathepsin D in breast cancer.

作者信息

Rochefort H

机构信息

Unité Hormones et Cancer (U 148) INSERM, University of Montpellier, France.

出版信息

Breast Cancer Res Treat. 1990 Jul;16(1):3-13. doi: 10.1007/BF01806570.

DOI:10.1007/BF01806570
PMID:2207345
Abstract

Cathepsin D is an acidic lysosomal protease present in all cells. In estrogen receptor positive and negative breast cancer cell lines, the mRNA coding for pro-cathepsin D is overexpressed and sorting and maturation of the pro-enzyme are altered, leading to accumulation of the active proteinase in large endosomes and to secretion of the precursor (52K protein). In MCF7 cells, the cathepsin D mRNA is induced directly and transcriptionally by estrogens and indirectly by growth factors. In vitro, pro-cathepsin D is an autocrine mitogen on breast cancer cells and can be auto-activated to degrade extracellular matrix and proteoglycans and to activate other proteinases in acidic microenvironments. In patients, there is a significant correlation between high cathepsin D concentrations in the cytosol of primary breast cancer and development of metastasis. This marker is independent of other prognostic factors and appears to be particularly useful in lymph node-negative tumors. These results suggest that overexpression and possible derouting of cathepsin D plays an important role in invasion and metastasis of breast cancer.

摘要

组织蛋白酶D是一种存在于所有细胞中的酸性溶酶体蛋白酶。在雌激素受体阳性和阴性的乳腺癌细胞系中,编码组织蛋白酶D原的mRNA过度表达,且该酶原的分选和成熟过程发生改变,导致活性蛋白酶在大的内体中积累,并分泌前体(52K蛋白)。在MCF7细胞中,组织蛋白酶D mRNA由雌激素直接转录诱导,并由生长因子间接诱导。在体外,组织蛋白酶D原是乳腺癌细胞上的一种自分泌有丝分裂原,在酸性微环境中可被自身激活,以降解细胞外基质和蛋白聚糖,并激活其他蛋白酶。在患者中,原发性乳腺癌细胞溶质中高浓度的组织蛋白酶D与转移的发生显著相关。该标志物独立于其他预后因素,在淋巴结阴性肿瘤中似乎特别有用。这些结果表明,组织蛋白酶D的过度表达和可能的异常转运在乳腺癌的侵袭和转移中起重要作用。

相似文献

1
Cathepsin D in breast cancer.乳腺癌中的组织蛋白酶D
Breast Cancer Res Treat. 1990 Jul;16(1):3-13. doi: 10.1007/BF01806570.
2
Regulation, clinical and biological significance of cathepsin D in breast cancer.
Rev Esp Fisiol. 1990 Mar;46(1):39-41.
3
Cathepsin D: a protease involved in breast cancer metastasis.组织蛋白酶D:一种参与乳腺癌转移的蛋白酶。
Cancer Metastasis Rev. 1990 Dec;9(4):321-31. doi: 10.1007/BF00049522.
4
Biological and clinical significance of cathepsin D in breast cancer.组织蛋白酶D在乳腺癌中的生物学及临床意义
Semin Cancer Biol. 1990 Apr;1(2):153-60.
5
Structure, function, regulation and clinical significance of the 52K pro-cathepsin D secreted by breast cancer cells.乳腺癌细胞分泌的52K组织蛋白酶D前体的结构、功能、调节及临床意义
Biochimie. 1988 Jul;70(7):943-9. doi: 10.1016/0300-9084(88)90236-2.
6
Overexpression and hormonal regulation of pro-cathepsin D in mammary and endometrial cancer.组织蛋白酶D原在乳腺癌和子宫内膜癌中的过表达及激素调控
J Steroid Biochem. 1989;34(1-6):177-82. doi: 10.1016/0022-4731(89)90080-0.
7
Oestrogen regulates cathepsin D mRNA levels in oestrogen responsive human breast cancer cells.雌激素调节雌激素反应性人乳腺癌细胞中组织蛋白酶D的mRNA水平。
Nucleic Acids Res. 1987 May 11;15(9):3773-86. doi: 10.1093/nar/15.9.3773.
8
[Estrogens, cathepsin D and metastasis in cancers of the breast and ovary: invasion or proliferation?].[雌激素、组织蛋白酶D与乳腺癌和卵巢癌转移:侵袭还是增殖?]
C R Seances Soc Biol Fil. 1998;192(2):241-51.
9
A mutated cathepsin-D devoid of its catalytic activity stimulates the growth of cancer cells.一种丧失催化活性的突变组织蛋白酶D会刺激癌细胞生长。
Oncogene. 2001 Oct 18;20(47):6920-9. doi: 10.1038/sj.onc.1204843.
10
Immunoradiometric assay of pro-cathepsin D in breast cancer cytosol: relative prognostic value versus total cathepsin D.乳腺癌细胞溶质中组织蛋白酶D前体的免疫放射分析:与总组织蛋白酶D相比的相对预后价值
Eur J Cancer. 1993;29A(9):1248-51. doi: 10.1016/0959-8049(93)90066-o.

引用本文的文献

1
A New Cathepsin D Targeting Drug Delivery System Based on Immunoliposomes Functionalized with Lipidated Pepstatin A.一种基于用脂化胃蛋白酶抑制剂A功能化的免疫脂质体的新型组织蛋白酶D靶向给药系统。
Pharmaceutics. 2023 Oct 14;15(10):2464. doi: 10.3390/pharmaceutics15102464.
2
Proteins Found in the Triple-Negative Breast Cancer Secretome and Their Therapeutic Potential.三阴性乳腺癌分泌组中的蛋白及其治疗潜力。
Int J Mol Sci. 2023 Jan 20;24(3):2100. doi: 10.3390/ijms24032100.
3
Breast ductal lavage for assessment of breast cancer biomarkers.

本文引用的文献

1
A secreted glycoprotein induced by estrogen in human breast cancer cell lines.一种由雌激素在人乳腺癌细胞系中诱导产生的分泌型糖蛋白。
Cell. 1980 Jun;20(2):353-62. doi: 10.1016/0092-8674(80)90621-2.
2
Lysosomal cathepsin B: correlation with metastatic potential.溶酶体组织蛋白酶B:与转移潜能的相关性。
Science. 1981 Jun 5;212(4499):1151-3. doi: 10.1126/science.7233209.
3
Effects of antiestrogens on the estrogen-regulated pS2 RNA and the 52- and 160-kilodalton proteins in MCF7 cells and two tamoxifen-resistant sublines.抗雌激素对MCF7细胞以及两个他莫昔芬耐药亚系中雌激素调节的pS2 RNA和52千道尔顿及160千道尔顿蛋白质的影响。
乳腺导管灌洗用于评估乳腺癌生物标志物。
Horm Cancer. 2010 Aug;1(4):197-204. doi: 10.1007/s12672-010-0021-y.
4
Immunoaffinity enrichment and liquid chromatography-selected reaction monitoring mass spectrometry for quantitation of carbonic anhydrase 12 in cultured renal carcinoma cells.免疫亲和富集和液相色谱-选择反应监测质谱法用于培养的肾癌细胞中碳酸酐酶 12 的定量。
Anal Chem. 2010 Nov 1;82(21):8998-9005. doi: 10.1021/ac101981t. Epub 2010 Oct 11.
5
Genes, chromatin, and breast cancer: an epigenetic tale.基因、染色质与乳腺癌:一个表观遗传学的故事。
J Mammary Gland Biol Neoplasia. 2001 Apr;6(2):169-82. doi: 10.1023/a:1011356623442.
6
Alpha1-antichymotrypsin and kallistatin hydrolysis by human cathepsin D.人组织蛋白酶D对α1-抗糜蛋白酶和血管舒缓素原的水解作用
J Protein Chem. 2000 Jul;19(5):411-8. doi: 10.1023/a:1026432402259.
7
Relationship of nm23 to proteolytic factors, proliferation and motility in breast cancer tissues and cell lines.nm23与乳腺癌组织及细胞系中蛋白水解因子、增殖和迁移的关系。
Br J Cancer. 1998 Sep;78(6):710-7. doi: 10.1038/bjc.1998.566.
8
Cathepsin D immunoreactivity in ovarian cancer: correlation with prognostic factors.卵巢癌中组织蛋白酶D免疫反应性:与预后因素的相关性
Pathol Oncol Res. 1998;4(2):103-7. doi: 10.1007/BF02904702.
9
Purification and characterization of cathepsin D from normal human breast tissue.从正常人乳腺组织中纯化和鉴定组织蛋白酶D
J Protein Chem. 1997 Apr;16(3):171-81. doi: 10.1023/a:1026322707644.
10
Body weight and vascular invasion in post-menopausal women with breast cancer.绝经后乳腺癌女性的体重与血管侵犯
Br J Cancer. 1997;75(6):910-3. doi: 10.1038/bjc.1997.160.
J Biol Chem. 1984 Aug 25;259(16):10030-5.
4
Metastatic potential correlates with enzymatic degradation of basement membrane collagen.转移潜能与基底膜胶原蛋白的酶促降解相关。
Nature. 1980 Mar 6;284(5751):67-8. doi: 10.1038/284067a0.
5
Cathepsin D. Purification of isoenzymes from human and chicken liver.组织蛋白酶D。从人及鸡肝脏中纯化同工酶。
Biochem J. 1970 Apr;117(3):601-7. doi: 10.1042/bj1170601.
6
Autocrine growth stimulation of the MCF 7 breast cancer cells by the estrogen-regulated 52 K protein.雌激素调节的52K蛋白对MCF 7乳腺癌细胞的自分泌生长刺激作用。
Endocrinology. 1986 Apr;118(4):1537-45. doi: 10.1210/endo-118-4-1537.
7
Cloning and sequence analysis of cDNA for human cathepsin D.人组织蛋白酶D的cDNA克隆与序列分析
Proc Natl Acad Sci U S A. 1985 Aug;82(15):4910-4. doi: 10.1073/pnas.82.15.4910.
8
Characterization of monoclonal antibodies to the estrogen-regulated Mr 52,000 glycoprotein and their use in MCF7 cells.雌激素调节的52,000道尔顿糖蛋白单克隆抗体的特性及其在MCF7细胞中的应用。
Cancer Res. 1985 Feb;45(2):709-16.
9
Purification and first characterization of the secreted and cellular 52-kDa proteins regulated by estrogens in human-breast cancer cells.人乳腺癌细胞中受雌激素调节的52 kDa分泌型和细胞型蛋白质的纯化及初步鉴定
Eur J Biochem. 1986 Dec 1;161(2):505-12. doi: 10.1111/j.1432-1033.1986.tb10471.x.
10
Distribution of the Mr 52,000 estrogen-regulated protein in benign breast diseases and other tissues by immunohistochemistry.
Cancer Res. 1986 Jul;46(7):3734-8.